🇮🇳India·Startups·27 May 2026·via The Economic Times
Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can reduce production time from several weeks to just one day and cut costs by nearly 70%, potentially making advanced cancer treatment more affor...
Share this article
Original reporting by The Economic TimesWe don't republish, read the full story →
Related reading
6 stories
🇮🇳·Startups
Quad Foreign Ministers Meet In Atlanta, Agree To Expand Joint Exercises And Maritime Surveillance
🇸🇬·Startups
Rare, roomy and pricey? Inside Singapore's niche jumbo HDB flat market
🇮🇳·Startups
Sanjay Gupta’s Last Rites Held In Mumbai, Abhishek Bachchan, Rakesh Roshan Pay Last Respects
🇮🇳·Startups
EVE NET Turns Spare Smartphone Capacity Into An AI Cloud
🇮🇳·Startups
Telangana Neta Natter | A Busload Of Trouble For Congress’s Delhi March
🇮🇳·Startups